OTC Medicines

Browse OTC Medicines Content

In recent years, several states have taken proactive steps to address plastic pollution and promote sustainability by implementing post-consumer recycled (PCR) content mandates for packaging. These laws require manufacturers to incorporate a minimum percentage of recycled materials in their packaging products.

Jul 9, 2024

CHPA Senior Vice President of Legal, Government Affairs & Policy David Spangler released the below statement today following the U.S. Supreme Court’s decision to overturn the Chevron standard, a principle of judicial deference used by federal courts for nearly four decades when reviewing a federal agency’s interpretation of a statute it administers:

Jun 28, 2024

CHPA and several of its member companies who manufacture and market leading over-the-counter oral care products, including Colgate-Palmolive, Haleon, Kenvue, Lornamead, Procter & Gamble, and Sanofi, joined Members of Congress on Capitol Hill this week to celebrate the introduction of HR 8599, the Oral Health Products Inclusion Act. 

Jun 14, 2024

(WASHINGTON, D.C.) The Consumer Healthcare Products Association (CHPA) today announced the election of new members to its board of directors during the association’s summer meeting this week in Washington.

Jun 14, 2024

CHPA submits these comments on FDA’s Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products; Draft Guidance for Industry issued on March 13, 2024.

May 13, 2024

CHPA released the below statement today following Governor Phil Scott signing S. 187 into law this week, legislation that will allow students to carry and self-apply sunscreen at school with the permission of a parent or guardian.

May 8, 2024

CHPA released the below statement today following Tennessee Governor Bill Lee's recent signing of Senate Bill 2048 into law, legislation that raises the monthly purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE) from 5.76 grams per month to 7.2 grams, allowing access to a full 30-day supply per month. The bill also raises the annual purchase limit to 43.2 grams, which is a 40% increase from the current limit of 28.8 grams.

May 7, 2024

CHPA Response to Study Published in Neurology Clinical Practice, Examining Prescription Acid Reflux Drugs:

Apr 25, 2024

In recent years, the issue of consumer data privacy has become increasingly important as technology continues to advance, and more personal information is collected and shared online. Despite the growing concerns over data privacy, the federal government has yet to enact comprehensive legislation addressing the issue. This lack of federal action has prompted many states to take matters into their own hands and introduce their own data privacy laws to protect their residents.

Apr 16, 2024

Filter Results